:quality(80)/s3.amazonaws.com/arc-authors/morningstar/27df33e4-c5eb-4dc8-805e-babc7c688b65.jpg)
Near-Term Biopharma Uncertainty Does Not Change Agilent's Long-Term Prospects
After Agilent was spun out from Hewlett Packard in 1999 and divested its electronic measurement business (Keysight Technologies) in November 2014, Agilent focuses on providing tools to analyze the structural properties of various chemicals, molecules, and cells. Agilent is one of the leading providers of chromatography and mass spectrometry tools, which have applications in a variety of end markets, including the healthcare, chemical, food, and environmental fields. While healthcare-related applications, including clinical diagnostics, remain Agilent’s largest end market, Agilent generates about half of its sales from nonhealthcare fields.